Heart Disease Trial, Recruiting NCT06911294 Sponsor: Catholic University of the Sacred Heart Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06911294
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 40 and 69 years old.
  • People whose 10-year heart and blood vessel disease risk score (called SCORE2) falls between 2.5% and 10% (confirm with trial site on how this is calculated).
  • People diagnosed with metabolic syndrome, meaning they have three or more of the following conditions: excess weight around the waist (over 40 inches/102 cm for men, or over 35 inches/89 cm for women); high triglyceride fat levels in the blood (150 mg/dL or higher, or currently taking medication for this); low levels of "good" HDL cholesterol (below 40 mg/dL for men or below 50 mg/dL for women, or currently taking cholesterol-lowering medication); high blood pressure (top number 130 or higher, or bottom number 85 or higher, or currently taking blood pressure medication); high fasting blood sugar levels (100 mg/dL or higher, or currently taking blood sugar-lowering medication).

Who may not be able to join:

  • People who have been diagnosed with diabetes.
  • People with a hereditary condition that causes very high cholesterol levels, known as familial hypercholesterolemia.
  • People who have previously had a heart attack, stroke, or other cardiovascular event.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393495624174

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Catholic University of the Sacred Heart
Registry
ClinicalTrials.gov
Start date
10 February 2025
Est. completion
10 February 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Feasibility for the patients; Feasibility for the General Practitioners

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov